148 related articles for article (PubMed ID: 32745462)
1. Heparanase Level and Procoagulant Activity Are Increased in Thalassemia and Attenuated by Janus Kinase 2 Inhibition.
Ghoti H; Ackerman S; Rivella S; Casu C; Nadir Y
Am J Pathol; 2020 Oct; 190(10):2146-2154. PubMed ID: 32745462
[TBL] [Abstract][Full Text] [Related]
2. JAK-2 V617F mutation increases heparanase procoagulant activity.
Kogan I; Chap D; Hoffman R; Axelman E; Brenner B; Nadir Y
Thromb Haemost; 2016 Jan; 115(1):73-80. PubMed ID: 26489695
[TBL] [Abstract][Full Text] [Related]
3. Heparanase procoagulant activity in cancer progression.
Nadir Y; Brenner B
Thromb Res; 2016 Apr; 140 Suppl 1():S44-8. PubMed ID: 27067977
[TBL] [Abstract][Full Text] [Related]
4. Heparanase procoagulant activity is elevated in women using oral contraceptives.
Matan M; Axelman E; Brenner B; Nadir Y
Hum Reprod; 2013 Sep; 28(9):2372-80. PubMed ID: 23800622
[TBL] [Abstract][Full Text] [Related]
5. Heparanase in the Coagulation System.
Nadir Y
Adv Exp Med Biol; 2020; 1221():771-784. PubMed ID: 32274737
[TBL] [Abstract][Full Text] [Related]
6. Heparanase procoagulant activity.
Nadir Y; Brenner B
Thromb Res; 2012 Apr; 129 Suppl 1():S76-9. PubMed ID: 22682139
[TBL] [Abstract][Full Text] [Related]
7. An assay to evaluate heparanase procoagulant activity.
Nadir Y; Kenig Y; Drugan A; Shafat I; Brenner B
Thromb Res; 2011 Oct; 128(4):e3-8. PubMed ID: 21481923
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the heparanase procoagulant domain in bleeding and wound healing.
Crispel Y; Ghanem S; Attias J; Kogan I; Brenner B; Nadir Y
J Thromb Haemost; 2017 Jul; 15(7):1463-1472. PubMed ID: 28439967
[TBL] [Abstract][Full Text] [Related]
9. Novel peptides that inhibit heparanase activation of the coagulation system.
Axelman E; Henig I; Crispel Y; Attias J; Li JP; Brenner B; Vlodavsky I; Nadir Y
Thromb Haemost; 2014 Sep; 112(3):466-77. PubMed ID: 25030319
[TBL] [Abstract][Full Text] [Related]
10. Heparanase procoagulant effects and inhibition by heparins.
Nadir Y; Brenner B
Thromb Res; 2010 Apr; 125 Suppl 2():S72-6. PubMed ID: 20434010
[TBL] [Abstract][Full Text] [Related]
11. Heparanase procoagulant activity is elevated and predicts survival in non-small cell lung cancer patients.
Nadir Y; Sarig G; Axelman E; Meir A; Wollner M; Shafat I; Hoffman R; Brenner B; Vlodavsky I; Haim N
Thromb Res; 2014 Sep; 134(3):639-42. PubMed ID: 25065557
[TBL] [Abstract][Full Text] [Related]
12. Heparanase procoagulant activity, factor Xa, and plasminogen activator inhibitor 1 are increased in shift work female nurses.
Nadir Y; Saharov G; Hoffman R; Keren-Politansky A; Tzoran I; Brenner B; Shochat T
Ann Hematol; 2015 Jul; 94(7):1213-9. PubMed ID: 25743687
[TBL] [Abstract][Full Text] [Related]
13. Heparanase procoagulant activity as a predictor of wound necrosis following diabetic foot amputation.
Peled E; Melamed E; Portal TB; Axelman E; Norman D; Brenner B; Nadir Y
Thromb Res; 2016 Mar; 139():148-53. PubMed ID: 26916313
[TBL] [Abstract][Full Text] [Related]
14. Heparanase coagulation and cancer progression.
Nadir Y; Brenner B
Best Pract Res Clin Haematol; 2009 Mar; 22(1):85-92. PubMed ID: 19285275
[TBL] [Abstract][Full Text] [Related]
15. Increased heparanase level and procoagulant activity in orthopedic surgery patients receiving prophylactic dose of enoxaparin.
Peled E; Rovitsky A; Axelman E; Norman D; Brenner B; Nadir Y
Thromb Res; 2012 Jul; 130(1):129-34. PubMed ID: 22154361
[TBL] [Abstract][Full Text] [Related]
16. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
[TBL] [Abstract][Full Text] [Related]
17. Heparanase enhances the generation of activated factor X in the presence of tissue factor and activated factor VII.
Nadir Y; Brenner B; Fux L; Shafat I; Attias J; Vlodavsky I
Haematologica; 2010 Nov; 95(11):1927-34. PubMed ID: 20634491
[TBL] [Abstract][Full Text] [Related]
18. Heparan sulfate chains contribute to the anticoagulant milieu in malignant pleural effusion.
Hardak E; Peled E; Crispel Y; Ghanem S; Attias J; Asayag K; Kogan I; Nadir Y
Thorax; 2020 Feb; 75(2):143-152. PubMed ID: 31892546
[TBL] [Abstract][Full Text] [Related]
19. Progestin type affects the increase of heparanase level and procoagulant activity mediated by the estrogen receptor.
Treger S; Ackerman S; Kaplan V; Ghanem S; Nadir Y
Hum Reprod; 2021 Jan; 36(1):61-69. PubMed ID: 33306105
[TBL] [Abstract][Full Text] [Related]
20. Heparanase, heparin and the coagulation system in cancer progression.
Vlodavsky I; Ilan N; Nadir Y; Brenner B; Katz BZ; Naggi A; Torri G; Casu B; Sasisekharan R
Thromb Res; 2007; 120 Suppl 2():S112-20. PubMed ID: 18023704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
